Jul 22, 2026 08:30AM
May 4, 2026 04:13PM
May 4, 2026 04:05PM
Apr 18, 2026 10:00PM
Apr 14, 2026 08:30AM
Mar 3, 2026 04:10PM
Mar 3, 2026 04:05PM Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability¹ Beginning in 2026
Feb 17, 2026 08:00AM
Jan 9, 2026 08:31AM
Jan 9, 2026 08:30AM
Nov 5, 2025 04:40PM
Nov 5, 2025 04:05PM
Oct 22, 2025 08:00AM
Aug 5, 2025 04:13PM Evolus (EOLS) Misses Q2 EPS by 17c
Aug 5, 2025 04:05PM
Jul 22, 2025 08:05AM
May 7, 2025 04:30PM
May 7, 2025 04:05PM
Apr 23, 2025 08:00AM
Mar 5, 2025 06:48AM
Mar 4, 2025 04:08PM Evolus (EOLS) Misses Q4 EPS by 13c, Beats on Revenue; Offers FY25 Revenue Guidance
Mar 4, 2025 04:05PM
Feb 18, 2025 08:00AM
Jan 21, 2025 08:04AM
Jan 21, 2025 08:00AM
Nov 6, 2024 04:31PM
Nov 6, 2024 04:05PM
Oct 23, 2024 08:00AM Evolus to Report Third Quarter Financial Results on November 6, 2024
Jul 31, 2024 04:25PM
Jul 31, 2024 04:05PM
Jul 17, 2024 08:00AM
May 7, 2024 04:44PM
May 7, 2024 04:05PM
Apr 23, 2024 04:30PM
Mar 7, 2024 04:17PM Evolus (EOLS) Misses Q4 EPS by 9c ; Offers Guidance
Mar 7, 2024 04:05PM
Mar 1, 2024 08:31AM
Mar 1, 2024 08:30AM
Feb 22, 2024 04:30PM
Jan 16, 2024 05:36PM
Jan 16, 2024 05:28PM
Dec 20, 2023 08:01AM Evolus (EOLS) Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe
Dec 20, 2023 08:00AM
Nov 7, 2023 04:43PM
Nov 7, 2023 04:16PM
Oct 25, 2023 08:45AM
Aug 2, 2023 04:23PM
Aug 2, 2023 04:05PM
Jul 27, 2023 08:45AM Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue
Jul 19, 2023 08:45AM

1,208,002 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All